![]() |
市场调查报告书
商品编码
1722547
2025 年至 2033 年註射器市场报告(按产品、材料、用途、配销通路、最终用户和地区)Syringes Market Report by Product, Material, Usage, Distribution Channel, End User, and Region 2025-2033 |
2024年全球注射器市场规模达211亿美元。展望未来,预计2033年市场规模将达到387亿美元,2025-2033年期间的成长率(CAGR)为6.99%。政府机构推出的鼓励个人快速安全接种疫苗的优惠政策是推动市场发展的因素之一。
主要市场驱动因素:慢性病盛行率的上升主要推动了市场的发展。此外,由于接受外科手术的人数不断增加,人们越来越倾向于使用一次性注射器输送麻醉剂,这也是另一个重要的成长诱导因素。
主要市场趋势:主要参与者越来越关注高效的消毒手术,同时避免医疗从业者和患者之间的感染,这是扩大市场的新兴趋势之一。除此之外,一次性医疗用品的广泛普及也对市场产生了进一步的正面影响。
竞争格局:全球市场上一些知名的公司包括 B. Braun Melsungen AG、Baxter International Inc.、Becton Dickinson and Company、Cardinal Health Inc.、Gerresheimer AG、Hindustan Syringes & Medical Devices Ltd.、Nipro Corporation、Pfizer Inc.、Retractable Technologies Inc.、Schott AG、Smiths Inc.、Schlct Group 等。
地理趋势:由于政府机构推出了许多安全和感染控制倡议,北美在市场上占据明显主导地位。此外,在预测期内,先进的製造流程将继续推动区域市场的发展。
挑战与机会:阻碍市场发展的关键因素之一是针刺伤的风险。然而,为医疗保健专业人员推出全面的培训计划以确保正确的使用和处置实践预计将在未来几年催化全球市场。
对先进註射器的需求
为提高注射器的安全性和功能性而引入的新技术正在对注射器市场前景产生积极的影响。例如,2024 年 3 月,领先的自毁式和一次性注射器製造商之一印度斯坦注射器和医疗器材公司 (HMD) 推出了自主研发的一次性安全注射器 Dispojekt,以最大限度地减少针刺伤的发生。此外,2024年5月,总部位于德国的医疗保健和医药包装公司Gerresheimer宣布扩建其位于墨西哥克雷塔罗的工厂,以提高即灌装(RTF)注射器的生产能力,从而满足北美市场的需求。此外,对家庭医疗保健的偏好转变以及生物製剂的日益普及也在推动市场的发展。例如,2024 年 3 月,药物包装解决方案和输送系统提供者之一 SCHOTT Pharma 在威尔逊建造了在美国的第一家工厂,用于生产预填充聚合物注射器,以满足 mRNA 药物深度冷藏和运输的需求。该工厂还可以生产用于 GLP-1 疗法(例如治疗糖尿病或肥胖症的疗法)的玻璃预填充注射器。
慢性病盛行率
癌症、糖尿病、心血管疾病等慢性疾病的发生率不断上升,使得透过注射器定期精确输送药物的需求日益增加。欧洲毒品和药物成瘾监测中心(EMCDDA)和欧洲疾病预防和控制中心(ECDC)于 2023 年 11 月发布的报告评估了包括针头和注射器计划(NSP)在内的干预措施在预防个人感染方面的有效性。此外,胰岛素注射器在糖尿病日常管理中的广泛使用也促进了市场的发展。例如,2023 年 11 月,Terumo India 推出了一款胰岛素注射器,这是一种为需要定期注射胰岛素的患者提供的无菌输送装置。它是 Terumo Medical Care Solutions 生命护理解决方案部门的新增部门。与此相符的是,该注射器专门设计有 3 斜面超锋利针头和高级硅胶表面,对患者来说更加温和舒适。其独特的柱塞保持技术可避免浪费和溢出。此外,美国糖尿病协会估计,美国有数百万人需要注射胰岛素,从而推动了对可靠且用户友好的注射器的需求。
更加重视安全
人们越来越重视改善医疗保健环境中的感染控制,从而刺激先进注射器技术的采用。例如,2024 年 5 月,小分子、生物製剂和疫苗无菌注射剂合约製造商之一 Grand River Aseptic Manufacturing (GRAM) 扩大了其註射器和药筒产能,为行业不断提升的生物製剂管道和患者自我给药的先进药物输送系统的增长提供更大的产能。除此之外,政府机构实施严格的规定,强制使用安全注射器以防止针刺伤,这也是一个重要的成长诱导因素。例如,2024 年 3 月,美国食品药物管理局 (FDA) 建议美国医疗保健机构立即停止使用某些未经授权的中国製造的塑胶注射器。这些建议不适用于预充式註射器、玻璃注射器或用于口服或外用的注射器。因此,领先的製造商正在透过推出必需的高品质医疗产品来应对,这将在未来几年继续支撑市场。例如,2024年3月,医疗技术公司BD(Becton, Dickinson and Company)提升了其在美国内布拉斯加州和康乃狄克州工厂的注射器国内生产能力,以满足客户需求。
The global syringes market size reached USD 21.1 Billion in 2024. Looking forward, the market is expected to reach USD 38.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.99% during 2025-2033. Favorable policies by government bodies for encouraging the fast and safe vaccination of individuals are among the factors fueling the market.
Major Market Drivers: The rising prevalence of chronic diseases is primarily bolstering the market. Moreover, the growing preference for single-use syringes to deliver anesthetics, owing to the increasing number of individuals who are undergoing surgical interventions, is also acting as another significant growth-inducing factor.
Key Market Trends: The inflating focus of key players on efficient sterilizing surgery while avoiding infections among healthcare practitioners and patients is one of the emerging trends augmenting the market. Apart from this, the widespread popularity of disposable medical supplies is further positively influencing the market.
Competitive Landscape: Some of the prominent companies in the global market include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., Nipro Corporation, Pfizer Inc., Retractable Technologies Inc., Schott AG, Smiths Group plc, Terumo Corporation, and Thomas Scientific LLC, among many others.
Geographical Trends: North America exhibits a clear dominance in the market, owing to the introduction of numerous initiatives by government bodies for safety and infection control. Furthermore, advanced manufacturing processes will continue to fuel the regional market over the forecasted period.
Challenges and Opportunities: One of the key factors hindering the market is the risk associated with needlestick injuries. However, the launch of comprehensive training programs for healthcare professionals to ensure proper usage and disposal practices is expected to catalyze the global market in the coming years.
Demand for Advanced Syringes
The introduction of novel advancements for enhancing the safety and functionality of syringes is positively influencing the syringes market outlook. For example, in March 2024, Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of auto-disable and disposable syringes, introduced Dispojekt, an indigenous single-use safety syringe to minimize instances of needle stick injuries. Besides this, in May 2024, Gerresheimer, a healthcare and pharmaceutical packaging company based in Germany, announced the expansion of its Queretaro facility in Mexico to increase the production capacities for ready-to-fill (RTF) syringes, thereby catering to the market demand in North America. Additionally, the shifting preference towards home-based healthcare, along with the elevating popularity of biologics, is also propelling the market. For instance, in March 2024, SCHOTT Pharma, one of the pharmaceutical drug containment solutions and delivery systems providers, built its first U.S. facility in Wilson to manufacture pre-fillable polymer syringes required to meet the need for deep-cold storage and transportation of mRNA medications. The site can further produce glass pre-fillable syringes for GLP-1 therapies, such as those that treat diabetes or obesity.
Prevalence of Chronic Diseases
The growing incidences of chronic diseases, including cancer, diabetes, cardiovascular disorders, etc., are escalating the need for regular and precise medication delivery via syringes. The report published by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the European Centre for Disease Prevention and Control (ECDC) in November 2023 assessed the effectiveness of interventions, including needle and syringe programs (NSPs), to prevent infections among individuals. Moreover, the widespread usage of insulin syringes for the daily management of diabetes is also bolstering the market. For instance, in November 2023, Terumo India launched an insulin syringe, a sterile delivery device for patients requiring regular insulin injections. It is the addition to the Life Care Solutions division of Terumo Medical Care Solutions. In line with this, specifically designed to have a 3-bevel super sharp needle with a high-grade silicone surface, the syringe is gentle and more comfortable for patients. Its unique feature with plunger retention technology avoids wastage and spillage. Furthermore, the American Diabetes Association estimated that millions of individuals in the U.S. require insulin injections, thereby driving the demand for reliable and user-friendly syringes.
Increasing Focus on Safety
There is a rising emphasis on improving infection control within healthcare settings, thereby stimulating the adoption of advanced syringe technologies. For example, in May 2024, Grand River Aseptic Manufacturing (GRAM), one of the sterile injectable contract manufacturers of small molecules, biologics, and vaccines, expanded its syringe and cartridge capacity to provide greater capacity for the industry's elevating biologics pipeline and the growth in advanced drug delivery systems for patient self-administration. Apart from this, the implementation of stringent regulations by government bodies that mandate the use of safety syringes to prevent needlestick injuries is further acting as a significant growth-inducing factor. For instance, in March 2024, the Food and Drug Administration (FDA) advised healthcare organizations in the U.S. to immediately transition away from using certain unauthorized plastic syringes made in China. The recommendations do not apply to pre-filled syringes, glass syringes, or syringes utilized for oral or topical purposes. Consequently, leading manufacturers are responding by introducing essential high-quality medical products, which will continue to bolster the market in the coming years. For example, in March 2024, BD (Becton, Dickinson and Company), one of the medical technology companies, elevated domestic manufacturing of syringes in Nebraska and Connecticut facilities, U.S., to cater to customer needs.
Among these, general syringes currently exhibit a clear dominance in the market
General syringes, essential tools in medical and healthcare settings, are continually evolving with advancements in technology and design aimed at improving safety, accuracy, and convenience. One of the notable launches is the Medtronic MiniMed 770G Insulin Pump System, which integrates advanced smart technology for precise insulin delivery, catering specifically to diabetes patients. General syringes improve user safety and reduce the risk of accidental injuries, thereby driving the segment's growth.
Currently, glass syringes hold the largest market share
Glass syringes are a crucial component in the medical field, valued for their durability, chemical resistance, and precise delivery capabilities. Unlike plastic syringes, they do not interact with the medications they contain, thereby making them ideal for administering highly reactive or sensitive drugs, such as biologics and certain vaccines. Their use is prominent in the pharmaceutical and biotechnology industries, where maintaining the integrity of the substance is paramount. In January 2024, Schreiner MediPharm, a Germany-based global provider of functional label solutions for the healthcare industry, developed barrier function labels that are generally designed to protect against oxygen ingress for drugs contained in COC syringes.
Disposable syringes hold the largest share in the market
Disposable syringes have become an indispensable tool in modern healthcare due to their convenience, affordability, and ability to reduce the risk of cross-contamination and infection significantly. Designed for single use, these syringes are typically made from plastic and come pre-sterilized, ensuring a high standard of hygiene. Their widespread adoption has been driven by health initiatives aiming to combat the spread of infectious diseases. According to the report by IMARC, the global disposable syringes market size reached US$ 15.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.
The offline segment, which includes hospitals, clinics, and retail pharmacies, continues to dominate the market due to the immediate availability of products and the trust consumers place in physical purchases, especially for critical healthcare supplies. This traditional distribution method is bolstered by strong relationships between manufacturers and healthcare providers, ensuring a steady supply chain and reliable access to syringes. Conversely, the online segment is experiencing rapid growth, driven by the increasing adoption of e-commerce platforms in the healthcare sector. Online distribution offers significant advantages such as convenience, wider product availability, and competitive pricing, which are particularly appealing to individual consumers and smaller healthcare facilities. Major players in the market, like Becton Dickinson (BD) and Terumo, are leveraging digital platforms to expand their reach and enhance customer engagement.
Syringes play a critical role across various healthcare settings. In hospitals and clinics, they are indispensable for a wide range of procedures, from routine vaccinations and blood draws to administering medications and intravenous therapies. Their reliability and ease of use make them a staple in these high-demand environments. Diagnostic centers heavily rely on syringes for sample collection and diagnostic testing, ensuring accurate and sterile handling of specimens. Specialty centers, such as oncology and diabetes care facilities, utilize them for precise administration of treatments like chemotherapy and insulin, which require meticulous dosing and safety. Other settings, such as outpatient care centers and emergency medical services, depend on syringes for immediate, on-the-go medical interventions, highlighting their versatility and importance in diverse medical scenarios.
North America currently dominates the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
As per the syringes market overview, the rising prevalence of chronic diseases, increased vaccination efforts, and advancements in medical technology are acting as growth-inducing factors in North America. Moreover, in the United States, stringent safety regulations set by the Occupational Safety and Health Administration (OSHA) have led to the widespread adoption of safety-engineered syringes that are designed to minimize needlestick injuries and enhance user safety. Besides this, the American Diabetes Association estimated that millions of individuals in the U.S. require insulin injections, thereby escalating the use of reliable and user-friendly syringes. Furthermore, prominent players like Becton Dickinson (BD) and Novo Nordisk are leading the market with their advanced insulin delivery systems.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
May 2024: Gerresheimer, one of the healthcare and pharmaceutical packaging companies based in Germany, expanded its Queretaro capacity of ready-to-fill (RTF) syringes in Mexico.
March 2024: SCHOTT Pharma built its first U.S. facility to manufacture pre-fillable polymer syringes required to meet the need for deep-cold storage and transportation of mRNA medications.
March 2024: Hindustan Syringes and Medical Devices (HMD), one of the leading providers of auto-disable and disposable syringes, launched Dispojekt, an indigenous single-use safety syringe to minimize instances of needle stick injuries.